IL6 and cervical carcinoma: To clarify the specific effects of IL-6, IL-8 on cervical cancer cell lines, we added human recombinant IL-6 and IL-8 proteins to anlotinib-treated CAF-CM and found that it restored the promotional effects on the proliferation and invasion of cervical cancer cell lines (Figures 7A, B).